Hüttmann A - Search Results

1

Determinants of resistance to engineered T cell therapies targeting CD19 in large B cell lymphomas.

Sworder BJ, Kurtz DM, Alig SK, Frank MJ, Shukla N, Garofalo A, Macaulay CW, Shahrokh Esfahani M, Olsen MN, Hamilton J, Hosoya H, Hamilton M, Spiegel JY, Baird JH, Sugio T, Carleton M, Craig AFM, Younes SF, Sahaf B, Sheybani ND, Schroers-Martin JG, Liu CL, Oak JS, Jin MC, Beygi S, Hüttmann A, Hanoun C, Dührsen U, Westin JR, Khodadoust MS, Natkunam Y, Majzner RG, Mackall CL, Diehn M, Miklos DB, Alizadeh AA. Sworder BJ, et al. Among authors: huttmann a. Cancer Cell. 2023 Jan 9;41(1):210-225.e5. doi: 10.1016/j.ccell.2022.12.005. Epub 2022 Dec 29. Cancer Cell. 2023. PMID: 36584673 Free PMC article.

2

Cloning and characterization of EphA3 (Hek) gene promoter: DNA methylation regulates expression in hematopoietic tumor cells.

Dottori M, Down M, Hüttmann A, Fitzpatrick DR, Boyd AW. Dottori M, et al. Among authors: huttmann a. Blood. 1999 Oct 1;94(7):2477-86. Blood. 1999. PMID: 10498621 Free article.

3

Phase I clinical and pharmacokinetic trial of the podophyllotoxin derivative NK611 administered as intravenous short infusion.

Rassmann I, Thödtmann R, Mross M, Hüttmann A, Berdel WE, Manegold C, Fiebig HH, Kaeser-Fröhlich A, Burk K, Hanauske AR. Rassmann I, et al. Among authors: huttmann a. Invest New Drugs. 1998-1999;16(4):319-24. doi: 10.1023/a:1006293830585. Invest New Drugs. 1998. PMID: 10426664 Clinical Trial.

4

Determination of the new podophyllotoxin derivative NK 611 in plasma by high-performance liquid chromatography with ultraviolet detection.

Hüttmann A, Mross K, Hossfeld DK. Hüttmann A, et al. J Chromatogr. 1993 Oct 29;620(2):233-8. doi: 10.1016/0378-4347(93)80009-s. J Chromatogr. 1993. PMID: 8300791

5

[Discovery of the electrical activity and conduction system of the heart].

Huttmann A. Huttmann A. Wien Klin Wochenschr. 1992;104(5):124-9. Wien Klin Wochenschr. 1992. PMID: 1574903 German.

6

[History of the institute of general and experimental pathology and the propedeutic clinic of the German University in Prague].

Huttmann A. Huttmann A. Wien Klin Wochenschr. 1990 Mar 16;102(6):161-71. Wien Klin Wochenschr. 1990. PMID: 2184589 German.

7

Older patients with chronic myeloid leukemia (≥65 years) profit more from higher imatinib doses than younger patients: a subanalysis of the randomized CML-Study IV.

Proetel U, Pletsch N, Lauseker M, Müller MC, Hanfstein B, Krause SW, Kalmanti L, Schreiber A, Heim D, Baerlocher GM, Hofmann WK, Lange E, Einsele H, Wernli M, Kremers S, Schlag R, Müller L, Hänel M, Link H, Hertenstein B, Pfirrman M, Hochhaus A, Hasford J, Hehlmann R, Saußele S; German Chronic Myeloid Leukemia Study Group; Schweizerische Arbeitsgemeinschaft für Klinische Krebsforschung (SAKK). Proetel U, et al. Ann Hematol. 2014 Jul;93(7):1167-76. doi: 10.1007/s00277-014-2041-0. Ann Hematol. 2014. PMID: 24658964 Free PMC article. Clinical Trial.

8

Functional heterogeneity within rhodamine123(lo) Hoechst33342(lo/sp) primitive hemopoietic stem cells revealed by pyronin Y.

Hüttmann A, Liu SL, Boyd AW, Li CL. Hüttmann A, et al. Exp Hematol. 2001 Sep;29(9):1109-16. doi: 10.1016/s0301-472x(01)00684-1. Exp Hematol. 2001. PMID: 11532352 Free article.

9

Bone marrow-derived stem cells and "plasticity".

Hüttmann A, Li CL, Dührsen U. Hüttmann A, et al. Ann Hematol. 2003 Oct;82(10):599-604. doi: 10.1007/s00277-003-0713-2. Epub 2003 Jul 24. Ann Hematol. 2003. PMID: 12898189 Review.

10

Porphyria cutanea tarda.

Christoph S, Hüttmann A, Dührsen U, Röth A. Christoph S, et al. Among authors: huttmann a. Br J Haematol. 2010 Feb;148(4):493. doi: 10.1111/j.1365-2141.2009.07821.x. Epub 2009 Jul 20. Br J Haematol. 2010. PMID: 19622066 Free article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

123 results

Search Page